CHINA-TIANJIN-DENMARK-NOVO NORDISK-INVESTMENT (CN)

CHINA-TIANJIN-DENMARK-NOVO NORDISK-INVESTMENT (CN)

(220923) -- TIANJIN, Sept. 23, 2022 (Xinhua) -- A staff member works at a lab of Novo Nordisk (China) Pharmaceutical Co., Ltd. in Tianjin, north China, Sept. 22, 2022. Over the past 20 years, Novo Nordisk, a pharmaceutical company from Denmark, has continuously increased its investment in China. Now, Novo Nordisk has already established a full value chain in the country, with one of its biggest manufacturing bases in Tianjin that supplies both Chinese and international markets with durable devices for insulin injection and insulin products. (Xinhua/Li Ran)

  • Product Code
  • ILEA001019753
  • Registered date
  • 2022/9/23 00:00:00
  • Credit
  • Xinhua / Kyodo News Images
  • Media source
  • Xinhua News Agency.All Rights Reserved
  • Media size
  • 5216 × 3241 pixel
  • Resolution
  • dpi
  • Deployment size
  • 2.44(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos